Anti-HIV-1 Activity of Elafin Is More Potent than Its Precursor's, Trappin-2, in Genital Epithelial Cells
- 15 April 2012
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 86 (8), 4599-4610
- https://doi.org/10.1128/jvi.06561-11
Abstract
Cervicovaginal lavage fluid (CVL) is a natural source of anti-HIV-1 factors; however, molecular characterization of the anti-HIV-1 activity of CVL remains elusive. In this study, we confirmed that CVLs from HIV-1-resistant (HIV-R) compared to HIV-1-susceptible (HIV-S) commercial sex workers (CSWs) contain significantly larger amounts of serine antiprotease trappin-2 (Tr) and its processed form, elafin (E). We assessed anti-HIV-1 activity of CVLs of CSWs and recombinant E and Tr on genital epithelial cells (ECs) that possess (TZM-bl) or lack (HEC-1A) canonical HIV-1 receptors. Our results showed that immunodepletion of 30% of Tr/E from CVL accounted for up to 60% of total anti-HIV-1 activity of CVL. Knockdown of endogenous Tr/E in HEC-1A cells resulted in significantly increased shedding of infectious R5 and X4 HIV-1. Pretreatment of R5, but not X4 HIV-1, with either Tr or E led to inhibition of HIV-1 infection of TZM-bl cells. Interestingly, when either HIV-1 or cells lacking canonical HIV-1 receptors were pretreated with Tr or E, HIV-1 attachment and transcytosis were significantly reduced, and decreased attachment was not associated with altered expression of syndecan-1 or CXCR4. Determination of 50% inhibitory concentrations (IC 50 ) of Tr and E anti-HIV-1 activity indicated that E is ∼130 times more potent than its precursor, Tr, despite their equipotent antiprotease activities. This study provides the first experimental evidence that (i) Tr and E are among the principal anti-HIV-1 molecules of CVL; (ii) Tr and E affect cell attachment and transcytosis of HIV-1; (iii) E is more efficient than Tr regarding anti-HIV-1 activity; and (iv) the anti-HIV-1 effect of Tr and E is contextual.This publication has 94 references indexed in Scilit:
- Synthesis, gp120 binding and anti-HIV activity of fatty acid esters of 1,1-linked disaccharidesBioorganic & Medicinal Chemistry, 2011
- Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infectionsJournal of Reproductive Immunology, 2011
- Epithelial cell secretions from the human female reproductive tract inhibit sexually transmitted pathogens and Candida albicans but not LactobacillusMucosal Immunology, 2010
- Syndecan-Fc Hybrid Molecule as a PotentIn VitroMicrobicidal Anti-HIV-1 AgentAntimicrobial Agents and Chemotherapy, 2010
- Trappin‐2/Elafin: a novel innate anti‐human immunodeficiency virus‐1 molecule of the human female reproductive tractImmunology, 2010
- Glycoside analogs of β-galactosylceramide, a novel class of small molecule antiviral agents that inhibit HIV-1 entryAntiviral Research, 2008
- A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycleAIDS, 2008
- WFDC1/ps20 Is a Novel Innate Immunomodulatory Signature Protein of Human Immunodeficiency Virus (HIV)-Permissive CD4+CD45RO+Memory T Cells That Promotes Infection by Upregulating CD54 Integrin Expression and Is Elevated in HIV Type 1 InfectionJournal of Virology, 2008
- Antimicrobial activity of omwaprin, a new member of the waprin family of snake venom proteinsBiochemical Journal, 2007
- Cell-Free Human Immunodeficiency Virus Type 1 Transcytosis through Primary Genital Epithelial CellsJournal of Virology, 2007